Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism

Molecular Medicine

Volumn 7, Issue 10, 2001, Pages 668-678

  Kinter, A L ^a   Biswas, P ^a   Alfano, M ^a   Justement, J S ^a   Mantelli, B ^a   Rizzi, C ^a   Gatti, A R ^a   Vicenzi, E ^a   Bressler, P ^a   Poli, G ^a  

^a P2 P3 Laboratories   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING PROTEIN 1; CHLORAMPHENICOL ACETYLTRANSFERASE; DEXAMETHASONE 21 MESILATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VIRION; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

EID: 0035163156     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401957     Document Type: Article

References (93)

1. Host factors and the pathogenesis of HIV-induced disease
2. Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: From bench to bedside
3. Sex hormones and glucocorticoids: Interactions with the immune system
4. An immunoendocrinological hypothesis of HIV infection
5. Prevalence of cortisol deficiency in late HIV disease
6. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection
7. "Buffalo hump" in men with HIV-1 infection
8. In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects
9. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk
10. Hydrocortisone and some other hormones enhance the expression of HTLV-III
11. Expression from the HIV-LTR is stimulated by glucocorticoids and pregnancy
12. Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat
13. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1
14. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression
15. Effect of glucocorticoids on chronic human immunodeficiency virus (HIV) infection and HIV promoter-mediated transcription
16. Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1
17. Cortisol upregulates HIV p24 antigen production in cultured human monocyte-derived macrophages
18. Upregulation of CCR2 chemokine receptor expression and increased susceptibility to the multitropic HIV strain 89.6 in monocytes exposed to glucocorticoid hormones
19. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance
20. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells
21. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA
22. Glucocorticoid-mediated inhibition of RANTES expression in human T lymphocytes
23. Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells
24. The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone
25. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis
26. Glucocorticosteroid-dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiation
27. Glucocorticoid upregulation of high-affinity interleukin 6 receptors on human epithelial cells
28. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes
29. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction
30. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils
31. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: Selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation
32. Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line
33. Structure, regulation and function of NF-kB
34. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms
35. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
36. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate
37. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency
38. The chronically infected cell line U1: A model of HIV expression regulated by cytokines
39. Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro
40. Comparison of DNA binding properties of activated, covalent and noncovalent glucocorticoid receptor-steroid complexes from HTC cells
41. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line
42. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2
43. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency
44. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line
45. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression
46. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
47. Studies on the structure and regulation of the human hepatic interleukin-6 receptor
48. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB
49. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: Inhibition of inductive effects by the interleukin 1 receptor antagonist
50. Steroid receptor regulated transcription of specific genes and gene networks
51. Nuclear receptor coactivators
52. Gene regulation by steroid hormones
53. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
54. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein- protein interaction
55. Distinct classes of transcriptional activating domains function by different mechanisms
56. Glucocorticoid-regulated stability of a constitutively expressed mouse mammary tumor virus glycoprotein
57. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus
58. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
59. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro
60. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor
61. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product
62. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1
63. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
64. Glucocorticoids inhibit the coordinated translation of alpha- and beta-globin mRNAs in Friend erythroleukemia cells
65. Glucocorticoid-mediated induction of alpha 1-acid glycoprotein: Evidence for hormone-regulated RNA processing
66. Dexamethasone control of growth hormone mRNA levels in GH3 pituitary cells is cycloheximide-sensitive and primarily posttranscriptional
67. Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation
68. Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms
69. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: The roles of mRNA accumulation, poly(A) tail shortening and translational efficiency
70. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells
71. Interleukin 6 induces the expression of vascular endothelial growth factor
72. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
73. Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1
74. The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites
75. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins
76. Transcriptional cross-talk, the second mode of steroid hormone receptor action
77. AP-1-glucocorticoid receptor crosstalk taken to a higher level
78. Glucocorticoids augment the chemically induced production and gene expression of interleukin-1alpha through NF-kappaB and AP-1 activation in murine epidermal cells
79. The regulation of AP-1 activity by mitogen-activated protein kinases
80. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
81. Alpha interferon suppresses virion but not soluble human immunodeficiency virus ntigen production in chronically infected T-lymphocytic cells
82. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines
83. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles
84. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase
85. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway
86. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid
87. Infection with HIV is associated with elevated 1L-6 levels and production
88. Cerebrospinal fluid analysis in HIV-1-infected children: Immunological and virological findings before and after AZT therapy
89. Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice
90. Prophylaxis and therapy for Pneumocystis pneumonia-where are we?
91. Pneumocystis carinii pneumonia
92. Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS
93. Cryptococcosis during systemic glucocorticosteroid treatment